Polymer-Free Drug-Eluting Stents: The Importance of the Right Control

Róisín Colleran^{1

2}, Robert A Byrne^{2

3}

Affiliations

¹ Deutsches Herzzentrum München, Technische Universität München, Munich, Germany (R.C.).
² Dublin Cardiovascular Research Institute, Mater Private Hospital, Ireland (R.C., R.A.B.).
³ School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin (R.A.B.).

Editorial

Róisín Colleran et al. Circulation. 2020.

. 2020 Jun 23;141(25):2064-2066.

doi: 10.1161/CIRCULATIONAHA.119.040556. Epub 2020 Jun 22.

Róisín Colleran^{1

2}, Robert A Byrne^{2

3}

¹ Deutsches Herzzentrum München, Technische Universität München, Munich, Germany (R.C.).
² Dublin Cardiovascular Research Institute, Mater Private Hospital, Ireland (R.C., R.A.B.).
³ School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin (R.A.B.).

No abstract available

Keywords: Editorials; drug-coated stent; drug-eluting stents; polymer coating; randomized clinical trial.

Comment on

Randomized Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent With the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated With Percutaneous Coronary Intervention: The SORT OUT IX Trial.
Jensen Lisette Okkels, Maeng M, Raungaard B, Kahlert J, Ellert J, Jakobsen L, Villadsen AB, Veien KT, Kristensen SD, Ahlehoff O, Carstensen S, Christensen MK, Terkelsen CJ, Engstroem T, Hansen KN, Bøtker HE, Aaroe J, Thim T, Thuesen L, Freeman P, Aziz A, Eftekhari A, Junker A, Jensen SE, Lassen JF, Hansen HS, Christiansen EH; Sort Out IX Study Group. Jensen Lisette Okkels, et al. Circulation. 2020 Jun 23;141(25):2052-2063. doi: 10.1161/CIRCULATIONAHA.119.040241. Epub 2020 May 21. Circulation. 2020. PMID: 32434381 Clinical Trial.